Stay updated on AZD4785 Phase I Dose-Escalation Clinical Trial
Sign up to get notified when there's something new on the AZD4785 Phase I Dose-Escalation Clinical Trial page.

Latest updates to the AZD4785 Phase I Dose-Escalation Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This is an internal version update with no visible changes to the study page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page shows a minor revision bump from v3.4.1 to v3.4.2 with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive content changes to the study details page were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a 'Show glossary' option and updated capitalization for certain labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), along with a new footer revision note 'Revision: v3.4.0'.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision label on the page updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a general Locations section with state listings and removed the separate Florida, Massachusetts, and Tennessee subsections; this alters how prospective participants view and locate active trial sites on the page.SummaryDifference0.5%

Stay in the know with updates to AZD4785 Phase I Dose-Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD4785 Phase I Dose-Escalation Clinical Trial page.